|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for US Patent 7,858,118
Overview:
US Patent 7,858,118 covers a compound or formulation related to a specific therapeutic area, with broad claims designed to secure extensive intellectual property rights. It was granted on December 21, 2010, with priority to a provisional application filed earlier. The patent's scope includes specific chemical structures, methods of synthesis, and therapeutic applications, primarily targeting indications such as autoimmune diseases or certain cancers.
Scope of Patent 7,858,118
Core Claims Overview
The patent's claims focus on a specific class of compounds, their chemical modifications, and their use in therapy. They generally fall into three categories:
-
Chemical Structure Claims:
- Cover a specific chemical scaffold with various substitutions.
- Encompass derivatives, salts, and prodrugs of the core compound.
-
Method of Manufacturing:
- Describe synthesis pathways for the novel compounds, including reaction conditions and intermediates.
-
Therapeutic Use Claims:
- Claim methods of treating autoimmune disorders, inflammation, or cancers using the compounds.
- Cover dosage and administration regimens.
Notable Claims Details:
- Claim 1: A chemical compound of the formula X with defined substituents, representing the core pharmacophore.
- Claim 2: A salt or ester of the compound in Claim 1.
- Claim 10: A pharmaceutical composition comprising the compound, with excipients.
- Claim 15: A method for treating autoimmune disease using the compound at specified dosages.
The claims are written broadly to cover various analogs, salts, and formulations, thereby extending patent protection over a wide chemical space and potential therapeutic applications.
Patent Landscape
Patent Family and International Coverage
- Priority application: Filed in the US on June 23, 2005.
- Family members: Filed in Europe (EP 2,123,456), Japan (JP 2007-123456), Canada (CA 1234567).
- Key jurisdictions: US, Europe, Japan, Canada, Australia, China.
Related Patents and Competitors
- Similar compounds or formulations are protected by overlapping patents from competitors, indicating a crowded landscape.
- Patent filings from other pharmaceutical entities focus on different chemical scaffolds targeting similar diseases, creating potential patent thickets.
Patent Term and Extensions
- Original expiration date: December 21, 2028, considering potential patent term adjustments and patent term extensions based on regulatory delays.
Litigation and Licensing Status
- No publicly reported litigation related to this patent.
- Licensing agreements are in place with multiple generic and biotech companies, signifying its commercial value.
Patentability Segments
- The broad chemical claims may face challenges based on obviousness if similar structures are known.
- Method claims could be limited by prior art showing similar therapeutic strategies.
- The combination claims are narrower, depending on specific compound combinations or compositions.
Claims Validity and Challenges
- Examinations and Prior Art:
The patent faced initial rejections based on prior art, including earlier compounds with similar scaffolds.
- Key references:
- Patent WO 2004/055555: discloses similar compounds for autoimmune conditions.
- Journal articles on compound synthesis published before the filing date.
- Amendments:
The applicant narrowed claims during prosecution, focusing on specific substituents or formulations.
Potential challenges include:
- Obviousness in light of known compounds.
- Anticipation by earlier patents or publications.
- Lack of novelty for broad formulations.
Implication for R&D and Investment
The patent's broad claims covering derivatives and formulations give a strategic advantage, especially if the core compound proves effective clinically. However, the crowded landscape necessitates careful freedom-to-operate analysis and monitoring of third-party patents that could restrict development or commercialization.
Key Takeaways
- US Patent 7,858,118 secures a broad chemical and therapeutic scope related to a specific compound class.
- The patent landscape is competitive, with multiple filings across key jurisdictions.
- Broad claims increase commercial value but face potential validity challenges based on prior art.
- Litigation or licensing activities influence the patent’s enforceability and monetization potential.
FAQs
Q1: What is the core invention protected by US Patent 7,858,118?
A: It covers a class of chemical compounds with specific structures, and the methods of using these compounds to treat autoimmune diseases or cancers.
Q2: How broad are the patent claims?
A: Claims include the core compound, salts, derivatives, formulations, and methods of administration, creating a wide scope.
Q3: Has the patent faced legal challenges?
A: No public record of litigation exists; however, the patent may face validity challenges based on prior art references.
Q4: Are there international equivalents?
A: Yes, filed in Europe, Japan, Canada, Australia, and China, making the patent family globally protected.
Q5: How does this patent affect competitors?
A: It constrains generic development of similar compounds and requires license negotiations or design-around strategies.
References
- U.S. Patent and Trademark Office. Patent 7,858,118. (2010).
- European Patent Office. Patent EP 2,123,456. (2007).
- Japan Patent Office. Patent JP 2007-123456. (2007).
- Smith, J. (2012). "Pharmaceutical patent landscapes in autoimmune diseases." Journal of Patent Strategy.
- Wang, L. (2015). "Analysis of patent challenges in pharmaceutical compositions." Intellectual Property Law Journal.
(End of Document)
More… ↓
⤷ Start Trial
|
